Increased nicotinic receptors in brains from smokers: Membrane binding and autoradiography studies

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 3, 1999, Pages 1545-1552

  Perry, David C ^a   Dávila García, Martha I ^b   Stockmeier, Craig A ^c   Kellar, Kenneth J ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN RECEPTOR; CYTISINE; EPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR;

ADULT; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CIGARETTE SMOKING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; TISSUE DISTRIBUTION; TISSUE SECTION;

ADULT; AGED; AGING; ALKALOIDS; AUTOPSY; AUTORADIOGRAPHY; AZOCINES; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEURONS; NICOTINIC AGONISTS; PREFRONTAL CORTEX; PYRIDINES; QUINOLIZINES; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; SMOKING; TEMPORAL LOBE; TRITIUM;

EID: 0344258434     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Alkondon M and Albuquerque EX (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473.
2. 3H]cytisine in the human brain, in Effects of Nicotine on Biological Systems II (Clarke PBS, Quik M, Adlkofer F, Thuray K eds) pp 363-369, Birkhauser Verlag, Basel.
3. Bencherif, M, Fowler, K, Lukas, RJ and Lippiello, PM (1995) Mechanism of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275:287-294.
4. 3H]nicotine binding sites in human brain. J Neurochem 50:1243-1247.
5. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 282:7-13.
6. Brioni JD, Decker MW, Sullivan JP and Arneric SP (1997)The pharmacology of (-) nicotine and novel cholinergic channel modulators, in Advances in Pharmacology 17 (August T, Anders M, Murad F and Coyle J eds) pp 153-211, Academic Press, San Diego.
7. Di Chiara G and Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
8. Fenster CP, Rains MF, Noerager B, Quick MW and Lester, RAJ (1997) Influence of subunit composition on desensitzation of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17:5747-5759.
9. Flores CM, Dávila-García MI, Ulrich YM and Kellar KJ (1997) Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem 69:2216-2219.
10. Flores CM, Rogers SW, Pabreza LA, Wolfe BB and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
11. Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S and Lindstrom J (1995) Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol 48:774-782.
12. Gopalakriahnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piatonni-Kaplan M, Donnelly-Roberts D, Arneric SP and Sullivan JP (1996) Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J Pharmacol Exp Ther 276:289-297.
13. 3H]cytisine binding to human brain membrane preparations. Brain Res 600:127-133.
14. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
15. 3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J Neurochem 66:667-675.
16. Hulihan-Giblin BA, Lumpkin MD and Kellar KJ (1990a) Acute effects of nicotine on prolactin release in the rat: Agonist and antagonist effects of a single injection of nicotine. J Pharmacol Exp Ther 252:15-20.
17. Hulihan-Giblin BA, Lumpkin MD and Kellar KJ (1990b) Effects of chronic administration of nicotine on prolactin release in the rat: Inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther 252:21-25.
18. Kellar KJ, Giblin BA and Lumpkin MD (1989) Regulation of brain nicotinic cholinergic recognition sites by nicotine. Prog Brain Res 78:209-216.
19. Langley JN and Dickinson WL (1889) On the local paralysis of peripheral ganglia and on the connection of different classes of nerve fibers. Proc Roy Soc London B Biol Sci 46:423-431.
20. Levin E D (1992) Nicotinic systems and cognitive function. Psychopharmacology 108:417-431.
21. Luetje CW and Patrick J (1991) Both α and β subunits contribute to the agonist sensitivity of neuronal acetylcholine receptors. J Neurosci 11:837-846.
22. Marks M J, Burch JB and Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817-825.
23. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF and Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765-2784.
24. Marks, MJ, Smith KW and Collins, AC (1998) Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther 285:377-386.
25. Olale F, Gerznich V, Kurytov A, Wang F and Lindstrom J (1997) Chronic nicotine exposure differentially affects the function of human α3, α4 and α7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther 283:675-683
26. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39:9-12.
27. Parker MJ, Beck A and Luetje CW (1998) Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity. Mol Pharmacol 54: 1132-1139.
28. Paton WDM (1954) Transmission in autonomic ganglia. Pharmacol Rev 6:59-67.
29. Peng X, Gerzanich V, Anand R, Whiting PJ and Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523-530.
30. Peng X, Gerzanich V, Anand R, Wang F and Lindstrom J (1997) Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 51:776-784.
31. 3H]Epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther 275:1030-1034.
32. 3H]nicotine binding in human cortex: Relative abundance in sub-icular complex. J Chem Neuroanat 5:399-405.
33. Perry DC, Dávila-García MI, Musachio JL and Kellar KJ (1997) Epibatidine analogs label subpopulation of neuronal nicotinic receptors. Soc Neurosci Abstr 23:382.
34. 3H]dopamine release by nicotine in rat nucleus accombens. J Neurochem 49:1449-1454.
35. Schwartz RD and Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in brain: regulation in vivo. Science 220:214-216.
36. Sharp BM and Beyer HS (1986) Rapid desenaitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J Pharmacol Exp Ther 238:486-491.
37. Whiteaker, P, Sharples, CGV and Wonnacott, S (1998) Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: Pharmacological and spatial definition. Mol Pharmacol 53:950-962.
38. Whitehouse PJ, Martino AM, Antouno PG, Lowenstein TR, Coyle JT, Price DL and Kellar KJ (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371:146-151.
39. Whiting P, Schoepfer R, Lindstrom J and Priestly T (1991) Structural and pharmacological characterization of the brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol Pharmacol 40:463-472.
40. Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J and Kellar KJ (1998) Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: Pharmacology of ligand binding and function. Mol Pharmacol 54:322-333.
41. Zoli M, Léna C, Picciotto MR and Changeux J-P (1998) Identification of four classes of brain nicotinic receptors using β2 mutant mice. J Neurosci 18:4461-4472.